<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35683480</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>30</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>The Long-Term Effect of COVID-19 Disease Severity on Risk of Diabetes Incidence and the Near 1-Year Follow-Up Outcomes among Postdischarge Patients in Wuhan.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3094</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm11113094</ELocationID><Abstract><AbstractText>We assessed the nearly 1-year health consequences following discharge and related risk factors of COVID-19 infection and further explored the long-term effect of COVID-19 disease severity on the risk of diabetes incidence. This prospective study included 248 COVID-19 patients discharged from Wuhan Hospital of Traditional Chinese Medicine who were followed up between 1 March and 10 June 2021. Logistic regression models were used to evaluate risk factors. The top ten symptoms were shortness of breath (30.3%), sore or dry throat (25.7%), cough (23.2%), expectoration (23.2%), body pain (22.3%), chest tightness (20.8%), palpitations (17.8%), sleep difficulties (17.0%), fatigue (16.6%), and anxiety (15.3%). Hypertension was associated with fatigue (OR = 2.51, 95% CI: 1.08, 5.80), shortness of breath (OR = 2.34, 95% CI: 1.16, 4.69), palpitations (OR = 2.82, 95% CI: 1.26, 6.31), expectoration (OR = 2.08, 95% CI: 1.01, 4.30), and sore or dry throat (OR = 2.71, 95% CI: 1.30, 5.65). Diabetes was associated with palpitations (OR = 3.22, 95% CI: 1.18, 8.81). Critical illness was associated with an increased risk of diabetes incidence after discharge (OR = 2.90, 95% CI: 1.07, 7.88), which seemed more evident in males. Long COVID-19 symptoms were common at 1-year postdischarge; hypertension and diabetes could be projected as potential risk factors. We are among the first researchers to find that critical illness is associated with incident diabetes after discharge.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Wuhan Hospital of Traditional Chinese Medicine, Wuhan 430022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shu</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Wuhan Hospital of Traditional Chinese Medicine, Wuhan 430022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Traditional Chinese Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Fengwen</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Boli</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Xuefeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education &amp; State Environmental Protection Key Laboratory of Health Effects of Environmental Pollution, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430030, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2020M680102</GrantID><Agency>China Postdoctoral Science Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">follow-up</Keyword><Keyword MajorTopicYN="N">incident diabetes</Keyword><Keyword MajorTopicYN="N">long-term effects</Keyword><Keyword MajorTopicYN="N">sequelae</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>10</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35683480</ArticleId><ArticleId IdType="pmc">PMC9181214</ArticleId><ArticleId IdType="doi">10.3390/jcm11113094</ArticleId><ArticleId IdType="pii">jcm11113094</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients with COVID-19: A Systematic Review. JAMA Netw. Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., Hu P., Guo L., Liu M., Xu J., et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao T., Meng D., Xiong L., Wu S., Yang L., Wang S., Zhou M., He X., Cao X., Xiong H., et al. Long-Term Effects of COVID-19 on Health Care Workers 1-Year Post-Discharge in Wuhan. Infect. Dis. Ther. 2021;11:145&#x2013;163. doi: 10.1007/s40121-021-00553-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-021-00553-0</ArticleId><ArticleId IdType="pmc">PMC8536919</ArticleId><ArticleId IdType="pubmed">34687442</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;lhave M., Leth S., Gunst J.D., Jensen-Fangel S., &#xd8;stergaard L., Wejse C., Agergaard J. Long-Term Symptoms among Hospitalized COVID-19 Patients 48 Weeks after Discharge&#x2014;A Prospective Cohort Study. J. Clin. Med. 2021;10:5298. doi: 10.3390/jcm10225298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10225298</ArticleId><ArticleId IdType="pmc">PMC8618663</ArticleId><ArticleId IdType="pubmed">34830580</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J., Waterboer T., Hippchen T., Simon J., Kirchner M., Lim A., M&#xfc;ller B., Merle U. Persistent symptoms in adult patients one year after COVID-19: A prospective cohort study. Clin. Infect. Dis. 2021;74:1191&#x2013;1198. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Liu X., Zhou Y., Yu H., Li R., Zhan Q., Ni F., Fang S., Lu Y., Ding X., et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study. Lancet Respir. Med. 2021;9:747&#x2013;754. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang F., Shen Y., Zhang X., Cen Y., Wang B., Zhao S., Zhou Y., Hu B., Wang M., et al. Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China. JAMA Netw. Open. 2021;4:e2127403. doi: 10.1001/jamanetworkopen.2021.27403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.27403</ArticleId><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Tao M., Shang L., Liu Y., Pan G., Jin Y., Wang L., Hu S., Li J., Zhang M., et al. Assessment of Sequelae of COVID-19 Nearly 1 Year After Diagnosis. Front. Med. 2021;8:717194. doi: 10.3389/fmed.2021.717194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.717194</ArticleId><ArticleId IdType="pmc">PMC8649686</ArticleId><ArticleId IdType="pubmed">34888318</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker C., Beck K., Zumbrunn S., Memma V., Herzog N., Bissmann B., Gross S., Loretz N., Mueller J., Amacher S.A., et al. Long COVID 1 year after hospitalisation for COVID-19: A prospective bicentric cohort study. Swiss Med. Wkly. 2021;151:w30091.</Citation><ArticleIdList><ArticleId IdType="pubmed">34694106</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X., Ming C., Cen Y., Lin H., Zhan K., Yang S., Li L., Cao G., Li Q., Ma X. Post-sequelae one year after hospital discharge among older COVID-19 patients: A multi-center prospective cohort study. J. Infect. 2021;84:179&#x2013;186. doi: 10.1016/j.jinf.2021.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.12.005</ArticleId><ArticleId IdType="pmc">PMC8662958</ArticleId><ArticleId IdType="pubmed">34902448</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman M., Prashar J., Hillman T.E., Marks M., Livingston R., A Ridsdale H., Roy K., Bell R., Zandi M., McNamara P., et al. Post-COVID-19 assessment in a specialist clinical service: A 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Respir. Res. 2021;8:e001041. doi: 10.1136/bmjresp-2021-001041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001041</ArticleId><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="pubmed">34764200</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino F., Amiel S.A., Zimmet P., Alberti G., Bornstein S., Eckel R.H., Mingrone G., Boehm B., Cooper M.E., Chai Z., et al. New-Onset Diabetes in Covid-19. N. Engl. J. Med. 2020;383:789&#x2013;790. doi: 10.1056/NEJMc2018688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2018688</ArticleId><ArticleId IdType="pmc">PMC7304415</ArticleId><ArticleId IdType="pubmed">32530585</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T., Kapoor N., Cao Y., Tapp R.J., Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis. Diabetes Obes. Metab. 2021;23:870&#x2013;874. doi: 10.1111/dom.14269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14269</ArticleId><ArticleId IdType="pmc">PMC7753574</ArticleId><ArticleId IdType="pubmed">33245182</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T., Tapp R.J., Cooper M.E., Zimmet P. Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes Metab. 2021;47:101204. doi: 10.1016/j.diabet.2020.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabet.2020.10.002</ArticleId><ArticleId IdType="pmc">PMC7591867</ArticleId><ArticleId IdType="pubmed">33129968</ArticleId></ArticleIdList></Reference><Reference><Citation>Landstra C.P., de Koning E.J.P. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course. Front. Endocrinol. 2021;12:649525. doi: 10.3389/fendo.2021.649525.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.649525</ArticleId><ArticleId IdType="pmc">PMC8247904</ArticleId><ArticleId IdType="pubmed">34220706</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi R.T., Lynch J.B., Del Rio C. Mild or Moderate Covid-19. N. Engl. J. Med. 2020;383:1757&#x2013;1766. doi: 10.1056/NEJMcp2009249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp2009249</ArticleId><ArticleId IdType="pubmed">32329974</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance. Pediatr. Med. Rodz. 2020;16:9&#x2013;26. doi: 10.15557/PiMR.2020.0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.15557/PiMR.2020.0003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L., Karakiulakis G., Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir. Med. 2020;8:e21. doi: 10.1016/S2213-2600(20)30116-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30116-8</ArticleId><ArticleId IdType="pmc">PMC7118626</ArticleId><ArticleId IdType="pubmed">32171062</ArticleId></ArticleIdList></Reference><Reference><Citation>Seiglie J., Platt J., Cromer S.J., Bunda B., Foulkes A.S., Bassett I.V., Hsu J., Meigs J.B., Leong A., Putman M.S., et al. Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19. Diabetes Care. 2020;43:2938&#x2013;2944. doi: 10.2337/dc20-1506.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-1506</ArticleId><ArticleId IdType="pmc">PMC7770271</ArticleId><ArticleId IdType="pubmed">32847827</ArticleId></ArticleIdList></Reference><Reference><Citation>Colafella K.M.M., Denton K.M. Sex-specific differences in hypertension and associated cardiovascular disease. Nat. Rev. Nephrol. 2018;14:185&#x2013;201. doi: 10.1038/nrneph.2017.189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.189</ArticleId><ArticleId IdType="pubmed">29380817</ArticleId></ArticleIdList></Reference><Reference><Citation>Poch D., Mandel J. Pulmonary Hypertension. Ann. Intern. Med. 2021;174:ITC49&#x2013;ITC64. doi: 10.7326/AITC202104200.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/AITC202104200</ArticleId><ArticleId IdType="pubmed">33844574</ArticleId></ArticleIdList></Reference><Reference><Citation>Thenappan T., Ormiston M.L., Ryan J.J., Archer S.L. Pulmonary arterial hypertension: Pathogenesis and clinical management. BMJ. 2018;360:j5492. doi: 10.1136/bmj.j5492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j5492</ArticleId><ArticleId IdType="pmc">PMC6889979</ArticleId><ArticleId IdType="pubmed">29540357</ArticleId></ArticleIdList></Reference><Reference><Citation>Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 2011;11:98&#x2013;107. doi: 10.1038/nri2925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2925</ArticleId><ArticleId IdType="pubmed">21233852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren H., Yang Y., Wang F., Yan Y., Shi X., Dong K., Yu X., Zhang S. Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19. Cardiovasc. Diabetol. 2020;19:58. doi: 10.1186/s12933-020-01035-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01035-2</ArticleId><ArticleId IdType="pmc">PMC7213552</ArticleId><ArticleId IdType="pubmed">32393351</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Wang X., Chen J., Zuo X., Zhang H., Deng A. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes. Metab. 2020;22:1935&#x2013;1941. doi: 10.1111/dom.14057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14057</ArticleId><ArticleId IdType="pmc">PMC7264681</ArticleId><ArticleId IdType="pubmed">32314455</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee Y.J., Ng S.J.H., Yeoh E. Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res. Clin. Pract. 2020;164:108166. doi: 10.1016/j.diabres.2020.108166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108166</ArticleId><ArticleId IdType="pmc">PMC7194589</ArticleId><ArticleId IdType="pubmed">32339533</ArticleId></ArticleIdList></Reference><Reference><Citation>Tittel S.R., Rosenbauer J., Kamrath C., Ziegler J., Reschke F., Hammersen J., M&#xf6;nkem&#xf6;ller K., Pappa A., Kapellen T., Holl R.W., et al. Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany? Diabetes Care. 2020;43:e172&#x2013;e173. doi: 10.2337/dc20-1633.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-1633</ArticleId><ArticleId IdType="pmc">PMC7576433</ArticleId><ArticleId IdType="pubmed">32826282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamrath C., Rosenbauer J., Eckert A.J., Siedler K., Bartelt H., Klose D., Sindichakis M., Herrlinger S., Lahn V., Holl R.W. Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry. Diabetes Care. 2022:dc210969. doi: 10.2337/dc21-0969.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-0969</ArticleId><ArticleId IdType="pubmed">35043145</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett C.E., Koyama A.K., Alvarez P., Chow W., Lundeen E.A., Perrine C.G., Pavkov M.E., Rolka D.B., Wiltz J.L., Bull-Otterson L., et al. Risk for Newly Diagnosed Diabetes &gt;30 Days After SARS-CoV-2 Infection Among Persons Aged 18 Years&#x2014;United States, March 1, 2020&#x2013;June 28, 2021. MMWR Morb. Mortal. Wkly. Rep. 2022 March 1;71:59&#x2013;65. doi: 10.15585/mmwr.mm7102e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7102e2</ArticleId><ArticleId IdType="pmc">PMC8757617</ArticleId><ArticleId IdType="pubmed">35025851</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathmann W., Kuss O., Kostev K. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia. 2022;65:949&#x2013;954. doi: 10.1007/s00125-022-05670-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-022-05670-0</ArticleId><ArticleId IdType="pmc">PMC8923743</ArticleId><ArticleId IdType="pubmed">35292829</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijls B.G., Jolani S., Atherley A., Dijkstra J.I., Franssen G.H., Hendriks S., Yu E.Y.-W., Zalpuri S., Richters A., Zeegers M.P. Temporal trends of sex differences for COVID-19 infection, hospitalisation, severe disease, intensive care unit (ICU) admission and death: A meta-analysis of 229 studies covering over 10M patients. F1000Research. 2022;11:5. doi: 10.12688/f1000research.74645.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.74645.1</ArticleId><ArticleId IdType="pmc">PMC9034173</ArticleId><ArticleId IdType="pubmed">35514606</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T., Ellingson M.K., Wong P., Israelow B., Lucas C., Klein J., Silva J., Mao T., Oh J.E., Tokuyama M., et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588:315&#x2013;320. doi: 10.1038/s41586-020-2700-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2700-3</ArticleId><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson N.M., Chen H.C., Lechner M.G., Su M.A. Sex Differences in Immunity. Annu. Rev. Immunol. 2022;40:75&#x2013;94. doi: 10.1146/annurev-immunol-101320-125133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-101320-125133</ArticleId><ArticleId IdType="pmc">PMC9805670</ArticleId><ArticleId IdType="pubmed">34985929</ArticleId></ArticleIdList></Reference><Reference><Citation>La Vignera S., Cannarella R., Condorelli R.A., Torre F., Aversa A., Calogero A.E. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis, D. Int. J. Mol. Sci. 2020;21:2948. doi: 10.3390/ijms21082948.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21082948</ArticleId><ArticleId IdType="pmc">PMC7215653</ArticleId><ArticleId IdType="pubmed">32331343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed M.S., Moulin T.C., Schioth H.B. Sex differences in COVID-19: The role of androgens in disease severity and progression. Endocrine. 2021;71:3&#x2013;8. doi: 10.1007/s12020-020-02536-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02536-6</ArticleId><ArticleId IdType="pmc">PMC7657570</ArticleId><ArticleId IdType="pubmed">33179220</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Narayan R.K., Kulandhasamy M., Prasoon P., Kumari C., Kumar S., Pareek V., Sesham K., Shekhawat P.S., Kant K., et al. COVID-19 pandemic: Insights into molecular mechanisms leading to sex-based differences in patient outcomes. Expert Rev. Mol. Med. 2021;23:e7. doi: 10.1017/erm.2021.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/erm.2021.9</ArticleId><ArticleId IdType="pmc">PMC8353216</ArticleId><ArticleId IdType="pubmed">34340720</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Han Y., Nilsson-Payant B.E., Gupta V., Wang P., Duan X., Tang X., Zhu J., Zhao Z., Jaffr&#xe9; F., et al. A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids. Cell Stem Cell. 2020;27:125&#x2013;136.e7. doi: 10.1016/j.stem.2020.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.06.015</ArticleId><ArticleId IdType="pmc">PMC7303620</ArticleId><ArticleId IdType="pubmed">32579880</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller J.A., Gross R., Conzelmann C., Kruger J., Merle U., Steinhart J., Weil T., Koepke L., Bozzo C.P., Read C., et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat. Metab. 2021;3:149&#x2013;165. doi: 10.1038/s42255-021-00347-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00347-1</ArticleId><ArticleId IdType="pubmed">33536639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzaroni M.G., Piantoni S., Masneri S., Garrafa E., Martini G., Tincani A., Andreoli L., Franceschini F. Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system. Blood Rev. 2021;46:100745. doi: 10.1016/j.blre.2020.100745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2020.100745</ArticleId><ArticleId IdType="pmc">PMC7444609</ArticleId><ArticleId IdType="pubmed">32868115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunnumakkara A.B., Rana V., Parama D., Banik K., Girisa S., Henamayee S., Thakur K.K., Dutta U., Garodia P., Gupta S.C., et al. COVID-19, cytokines, inflammation, and spices: How are they related? Life Sci. 2021;284:119201. doi: 10.1016/j.lfs.2021.119201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119201</ArticleId><ArticleId IdType="pmc">PMC7884924</ArticleId><ArticleId IdType="pubmed">33607159</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L., Girgis C.M., Cheung N.W. COVID-19 and diabetes: Insulin requirements parallel illness severity in critically unwell patients. Clin. Endocrinol. 2020;93:390&#x2013;393. doi: 10.1111/cen.14288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14288</ArticleId><ArticleId IdType="pmc">PMC7404426</ArticleId><ArticleId IdType="pubmed">32683745</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein S.R., Rubino F., Khunti K., Mingrone G., Hopkins D., Birkenfeld A.L., Boehm B., Amiel S., Holt R.I.G., Skyler J.S., et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8:546&#x2013;550. doi: 10.1016/S2213-8587(20)30152-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30152-2</ArticleId><ArticleId IdType="pmc">PMC7180013</ArticleId><ArticleId IdType="pubmed">32334646</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>